Back to Agenda
Enhancing Evidence Generation across the Product Life Cycle
Session Chair(s)
Alison Cave, PhD
Chief Safety Officer
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Enhancing Evidence Generation across the Product Life Cycle
Speaker(s)
![Edward McKone](/_Images/member/Generic_Image_Missing-Profile.jpg)
Use of Registry Data for Defining Clinical Care Pathways, Unmet Need and the Future – Registry Trails
Edward McKone
St. Vincent's University Hospital, Ireland
Professor, School of Medicine
Upholding and Enhancing Robust and Effective Real World Evidence Generation
Andrew Bate, PhD, MA
GlaxoSmithKline, United Kingdom
Vice President, Head of Safety Innovation and Analytics
![John Rigg](/_Images/member/Generic_Image_Missing-Profile.jpg)
Panel Discussion
John Rigg
IQVIA, United Kingdom
Head of Predictive Analytics
Panel Discussion
David Martin, MD, MPH
Moderna, United States
Vice President, Global Head RWE
![Deborah Morrison](/_Images/member/Generic_Image_Missing-Profile.jpg)
Panel Discussion
Deborah Morrison
National Institute for Health and Care Excellence (NICE), United Kingdom
Senior Scientific Adviser
Have an account?